Did You Know...
...that Kleenex tissue was originally designed to be a gas mask filter? It was developed at the beginning of World War I to replace cotton, which was then in short supply as a surgical dressing.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 6903127 | Method of treating sexual disturbances The present invention is a method of treating sexual disturbances in humans and inducing mating in non-human mammals using the compounds of formula (A) in a dosage range where the sexually therapeutic amount is from ab... | 06/07/2005 |
| 6894060 | Method for the treatment of dermal lesions caused by envenomation A method of treating dermal lesions caused by envenomation comprising applying a therapeutically effective amount of an immune response modifier compound selected from the group consisting of imidazoquinoline amines, imidazopyridine amines, 6,7-fused cycloalkylimida... | 05/17/2005 |
| 6855721 | Methods and compositions for alleviating stuttering Methods of treating stuttering include treating people with gamma-aminobutyric acid (GABA) receptor modulators, including cyclopyrrolones. A second active agent may be used with GABA receptor modulators. Active enantiomers, active metabolites, and pharmaceutically a... | 02/15/2005 |
| 6833373 | Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia The present invention provides methods to treat or prevent neoplasia disorders in a mammal using a combination of an integrin antagonist and an antineoplastic agent. ... | 12/21/2004 |
| 6809112 | Method of treating sexual disturbances The present invention is a method of treating sexual disturbances in humans and inducing mating in non-human mammals using the compounds of formula (A) in a dosage range where the sexually therapeutic amount is from ab... | 10/26/2004 |
| 6794374 | Use of Δ5-androstene-3β-OL7,17-dione in the treatment of arthritis Arthritis can be treated by administering therapeutic amounts of Δ5-androstene-3β-ol-7,17-dione and metabolizable precursors thereof, such a Δ5-androstene-3β-acetoxy-7,17-dione, which are readily metabolized in vivo to Δ5-androstene-3β-ol-7,17-dione but are no... | 09/21/2004 |
| 6794373 | Contraceptive methods using benzimidazolones This invention relates to cyclic combination therapies and regimens utilizing indoline compounds which are antagonists of the progesterone receptor and having the general structure: A is O, S, or NR4; B is a b... | 09/21/2004 |
| 6784168 | Biocidal compositions and treatments A synergistic biocide comprises a tris(hydroxymethyl)phosphine or a tetrakis (hydroxymethyl)phosphonium salt and at least one non-surfactant biopenetrant, such as a polymer or copolymer having a plurality of quaternary ammonium groups, a hydrotrope or a syntan, toge... | 08/31/2004 |
| 6774122 | Formulation The invention relates to a novel sustained release pharmaceutical formulation adapted for administration by injection containing the compound 7α-[9-(4,4,5,5,5-pentafluoropentylsulphinyl)nonyl]oestra-1,3,5(10)-triene-3,17β-diol, more particularly to a formulation a... | 08/10/2004 |
| 6753013 | Pharmaceutical composition A pharmaceutical composition for dermal use, wherein the composition has a first pharmacologically active component A consisting of at least one vitamin D or vitamin D analogue, and a second pharmacologically active component B consisting of at least one corticoster... | 06/22/2004 |
| 6753339 | Fungicide compositions The invention concerns fungicide compositions comprising a compound (I) which is (4-S)-4-mehtyl-2-methylthio-4-phenyl-1-phenylamino-2-imidazoline-5-one and a compound (II) which is N1-[(R)-1-(6-fluoro-2-benzothiazolyl)ethyl]-N2-isopropoxycarbon... | 06/22/2004 |
| 6753325 | Composition and method for prevention, reduction and treatment of radiation dermatitis A composition for the preventing, reducing or treating radiation dermatitis includes a mixture of one or more compounds that regulates cell differentiation and/or cell proliferation, and one or more antioxidants formulated in a pharmaceutically acceptable carrier. T... | 06/22/2004 |
| 6740681 | Pharmaceutical compositions comprising thiram Thiram (tetramethyliuram disulfide) is shown to inhibit angiogenesis and/or inflammation and to be useful in the treatment of angiogenesis-dependent disorders, including neoplasms, and in the inhibition, treatment and allevation of inflammation associated with sever... | 05/25/2004 |
| 6737437 | EP4 receptor selective agonists in the treatment of osteoporosis This invention is directed to methods of treating conditions which present with low bone mass, particularly osteoporosis, frailty, an osteoporotic fracture, a bone defect, childhood idiopathic bone loss, alveolar bone loss, mandibular bone loss, bone fracture, osteo... | 05/18/2004 |
| 6734175 | Treatments for obesity and methods for identifiying compounds useful for treating obesity The present invention provides a method of treating obesity, sexual dysfunction (including erectile dysfunction), diabetes, insulin resistance, hyperinsulinemia, Syndrome X, adrenal dysfunction, hypertension, hypercholesterolemia, atherosclerosis, hyperlipoproteinem... | 05/11/2004 |
| 6723311 | Clear, cosmetic preparations containing fatty alcohol polyglycol ethers, ether sulfates and/or alk(en)yl oligoglycosides, and methods of preparing the same Cosmetic preparations comprising: (a) a mixture of two or more surfactants selected from the group consisting of (a1) fatty alcohol polyglycol ether sulfates, (a2) fatty alcohol polyglycol ethers, and (a3) alk(en)yl oligoglycosides; and (b) one or more oil component... | 04/20/2004 |
| 6680308 | Use of organophosphorus compounds for the therapeutic and prophylactic treatment of infections Use of organophosphorus compounds of general Formula (I) ##STR1## for the therapeutic and prophylactic treatment of infections in humans and animals caused by viruses, fungi and parasites.... | 01/20/2004 |
| 6673840 | Use of lipoxygenase metabolite of arachidonic acid and its derivatives in capsaicin-channel agonist Disclosed is the use of metabolites produced from arachiconic acid by the catalytic action of lipoxygenase as capsaicin-channel or- receptor agonists. The lipoxygenase metavolites of arachidonic acid and their derivatives can activate the capsaicin channe... | 01/06/2004 |
| 6670349 | Composition & method for altering levels of or sensitivity to adenosine with a dehydroepiandrosterone &/or a ubiquinone A method of treating adenosine depletion in a subject in need of such treatment is disclosed. The method comprises administering to the subject folinic acid or a pharmaceutically acceptable salt thereof in an amount effective to treat adenosine depletion.... | 12/30/2003 |
| 6652842 | Deodorant compositions comprising diglycerol Cosmetic compositions, particularly solid or gel stick type deodorant compositions, comprising a base solvent system having at least diglycerol, and optionally polyhydric alcohols, and water and gelled with alkali metal salts of saturated fatty acids. The... | 11/25/2003 |
| 6649601 | Process for increasing the egg production and strengthening the eggshells of poultry The present invention relates to a process for increasing the egg production and strengthening the eggshells of poultry, which comprises the administration to the animal of at least one bisphosphonic compound chosen from a bisphosphonic acid, a physiologi... | 11/18/2003 |
| 6645954 | Compositions comprising ethisterone or its derivatives Treatment of androgen deficiency using a pharmaceutically effective dose of ethisterone or an ethisterone derivative such as Danazol. In particular, androgen deficiency in the aging male, also known as the male climacteric andropause or the male menopause... | 11/11/2003 |
| 6635646 | Pegylated interferon alfa-CCR5 antagonist combination HIV therapy Methods for treating treatment-naive as well as treatment-experienced adult and pediatric patients having HIV-1 infections as well as patients co-infected with HIV-1 and HCV involving administering a therapeutically effective amount of pegylated interfero... | 10/21/2003 |
| 6632834 | Compositions and methods for treating conditions responsive to estrogen This invention relates to methods, pharmaceutical compositions and kits useful in treating conditions responsive to estrogen by the administration of estrogen agonists/antagonists. Conditions responsive to the compositions and methods include rheumatoid a... | 10/14/2003 |
| 6627622 | (20S)-1-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses This invention discloses (20S)-1-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and pharmaceutical uses therefor. This compound exhibits pronounced activity in arresting the proliferation of undifferentiated cells and inducing their differ... | 09/30/2003 |
| 6620802 | Methods of treating mild cognitive impairment using a glucocorticoid-specific receptor antagonist This invention generally pertains to the field of psychiatry. In particular, this invention pertains to the discovery that agents which inhibit the binding of cortisol to its receptors can be used in methods for treating mild cognitive impairment. Mifepri... | 09/16/2003 |
| 6593362 | Non-peptidic cyclophilin binding compounds and their use This invention relates to pharmaceutical compositions and methods of using non-peptidic cyclophilin-binding compounds in medical conditions involving breakdown of mitochondrial energy metabolism induced by calcium overload, in treating alopecia and promot... | 07/15/2003 |
| 6586453 | Substituted thiazoles and the use thereof as inhibitors of plasminogen activator inhibitor-1 The present invention relates to the use of aminothiazole derivatives of Formula I of as inhibitors of PAI-1, and to novel classes of aminothiazole derivatives, their synthesis and their use as inhibitors of PAI-1. It has been discovered that compounds of... | 07/01/2003 |
| 6579906 | Dendrimer biocide-silver nanocomposites: their preparation and applications as potent antimicrobials A novel cationic dendrimer biocide-silver nanocomposite and methods for its use as a biocide. The biocidal nanocomposites of the present invention are effective against a variety of microbial species, including anthrax. The invention is also highly stable... | 06/17/2003 |
| 6548544 | Method of treatment of priapism without raising systemic blood pressure Treatment or prophylaxis of persistent penile erection resulting from, for example, physiological dysfunction, trauma, surgical intervention, or chemical induction. The method of the present invention is practiced by the administration of an agent capable... | 04/15/2003 |
| 6544970 | Cyclic regimens utilizing indoline derivatives This invention relates to cyclic combination therapies and regimens utilizing substituted indoline derivative compounds which are antagonists of the progesterone receptor having the general structure: ##STR1## wherein R1 and R2 may b... | 04/08/2003 |
| 6534539 | Pharmaceutical composition and method for treatment of dyspepsia The present invention relates to compositions containing lipase inhibitors, e.g. orlistat, and the use of such compositions for treating, reducing or preventing functional dyspepsiaafter ingestion of meals, especially of fat containing or fat rich meals.... | 03/18/2003 |
| 6534528 | Utilization of powder preparations containing hydroxypyridones for treating leg ulcers and decubitus ulcers The inventive powder preparations containing at least one compound of formula (I) are suited for treating leg ulcers or decubitus ulcers. ##STR1##... | 03/18/2003 |
| 6531462 | Medicament for treating obesity and improving lipid metabolism A medicament for preventive and therapeutic treatment of obesity and a disease with abnormal lipid metabolism which comprises a 24-alkylcholest-5-en-3-one as an active ingredient.... | 03/11/2003 |
| 6512004 | Promoters of neural regeneration The invention provides methods and compositions for promoting neural cell growth and/or regeneration. The general methods involve contacting with an activator of a cyclic nucleotide dependent protein kinase a neural cell subject to growth repulsion mediat... | 01/28/2003 |
| 6498154 | Cyclic regimens using quinazolinone and benzoxazine derivatives This invention relates to cyclic combination therapies utilizing, in combination with progestins, estrogens, or both, compounds which are progesterone receptor antagonists of the general structure: ##STR1## wherein: R1 and R2 are H, ... | 12/24/2002 |
| 6495584 | Use of 3-(1H-imidazol-4-ylmethyl)-indan-5-ol in the manufacture of a medicament for intraspinal, intrathecal or epidural administration The present invention relates to a method for obtaining analgesia by administering 3-(1H-imidazol-4-ylmethyl)-indan-5-ol, its enetiomer or pharmaceutically acceptable ester or salt thereof to a mammal intraspinally, 3-(1H-imidazol-4-ylmethyl)-indan-5-ol, ... | 12/17/2002 |
| 6492425 | Inhibitors of transcription factor-NF-.kappa.B The present invention provides pharmaceutical compositions of salicylanilide inhibitors of transcription factor NF-.kappa.B, and methods for treating diseases in which activation of NF-.kappa.B is implicated. More specifically, the present invention provi... | 12/10/2002 |
| 6492423 | Diketoacid-derivatives as inhibitors of polymerases ##STR1## Diketoacids of Formula (A) are useful as inhibitors of viral polymerases. In particular hepatitis C virus RNA dependent RNA polymerase (HCV RdRp), hepatitis B virus polymerase (HBV pol) and reverse transcriptase of human immunodeficiency virus (H... | 12/10/2002 |
| 6482826 | Method of treating alopecia Method of treating individuals with alopecia or having inferior quality hair, by administering to the scalp of said individuals an effective amount of ketoconazole. Novel compositions comprising as an active ingredient ketoconazole and an inert carrier.... | 11/19/2002 |
